223 related articles for article (PubMed ID: 20406312)
1. Generic-only drug coverage in the Medicare Part D gap and effect on medication cost-cutting behaviors for patients with diabetes mellitus: the translating research into action for diabetes study.
Duru OK; Mangione CM; Hsu J; Steers WN; Quiter E; Turk N; Ettner SL; Schmittdiel JA; Tseng CW
J Am Geriatr Soc; 2010 May; 58(5):822-8. PubMed ID: 20406312
[TBL] [Abstract][Full Text] [Related]
2. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
3. Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.
Patel RA; Walberg MP; Tong E; Tan F; Rummel AE; Woelfel JA; Carr-Lopez SM; Galal SM
J Manag Care Spec Pharm; 2014 Mar; 20(3):283-90. PubMed ID: 24564812
[TBL] [Abstract][Full Text] [Related]
4. Patient and Payer Incentives to Use Patented Brand-Name Drugs vs Authorized Generic Drugs in Medicare Part D.
Dusetzina SB; Sarpatwari A; Carrier MA; Hansen RA; Keating NL; Huskamp HA
JAMA Intern Med; 2021 Dec; 181(12):1605-1611. PubMed ID: 34661600
[TBL] [Abstract][Full Text] [Related]
5. Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes.
Fung V; Mangione CM; Huang J; Turk N; Quiter ES; Schmittdiel JA; Hsu J
Health Serv Res; 2010 Apr; 45(2):355-75. PubMed ID: 20050931
[TBL] [Abstract][Full Text] [Related]
6. The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure.
Baik SH; Rollman BL; Reynolds CF; Lave JR; Smith KJ; Zhang Y
J Ment Health Policy Econ; 2012 Sep; 15(3):105-18. PubMed ID: 23001279
[TBL] [Abstract][Full Text] [Related]
7. Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries.
Sacks NC; Burgess JF; Cabral HJ; Pizer SD; McDonnell ME
J Gen Intern Med; 2013 Jul; 28(7):876-85. PubMed ID: 23404199
[TBL] [Abstract][Full Text] [Related]
8. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
J Manag Care Spec Pharm; 2014 Aug; 20(8):862-76. PubMed ID: 25062080
[TBL] [Abstract][Full Text] [Related]
9. Effects of Medicare Part D coverage gap on medication adherence.
Zhang Y; Baik SH; Lave JR
Am J Manag Care; 2013 Jun; 19(6):e214-24. PubMed ID: 23844750
[TBL] [Abstract][Full Text] [Related]
10. Patient-provider communication regarding drug costs in Medicare Part D beneficiaries with diabetes: a TRIAD Study.
Schmittdiel JA; Steers N; Duru OK; Ettner SL; Brown AF; Fung V; Hsu J; Quiter E; Tseng CW; Mangione CM
BMC Health Serv Res; 2010 Jun; 10():164. PubMed ID: 20546616
[TBL] [Abstract][Full Text] [Related]
11. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
[TBL] [Abstract][Full Text] [Related]
12. Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan.
Nair KV; Frech-Tamas F; Jan S; Wolfe P; Allen RR; Saseen JJ
J Health Care Finance; 2011; 38(2):38-53. PubMed ID: 22372031
[TBL] [Abstract][Full Text] [Related]
13. Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes.
Williams J; Steers WN; Ettner SL; Mangione CM; Duru OK
Med Care; 2013 Feb; 51(2):193-8. PubMed ID: 23032359
[TBL] [Abstract][Full Text] [Related]
14. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
[TBL] [Abstract][Full Text] [Related]
15. Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression.
Zhang Y; Baik SH; Zhou L; Reynolds CF; Lave JR
Arch Gen Psychiatry; 2012 Jul; 69(7):672-9. PubMed ID: 22752233
[TBL] [Abstract][Full Text] [Related]
16. Potential savings associated with drug substitution in Medicare Part D: the Translating Research into Action for Diabetes (TRIAD) study.
Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF; Fu J; Simien L; Tseng CW
J Gen Intern Med; 2014 Jan; 29(1):230-6. PubMed ID: 23975059
[TBL] [Abstract][Full Text] [Related]
17. Cancer History, Health Insurance Coverage, and Cost-Related Medication Nonadherence and Medication Cost-Coping Strategies in the United States.
Zhao J; Zheng Z; Han X; Davidoff AJ; Banegas MP; Rai A; Jemal A; Yabroff KR
Value Health; 2019 Jul; 22(7):762-767. PubMed ID: 31277821
[TBL] [Abstract][Full Text] [Related]
18. Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.
Yala SM; Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF
BMC Health Serv Res; 2014 Dec; 14():665. PubMed ID: 25526892
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of Medicare drug plans in schizophrenia and bipolar disorder.
Smith KJ; Baik SH; Reynolds CF; Rollman BL; Zhang Y
Am J Manag Care; 2013 Feb; 19(2):e55-63. PubMed ID: 23448115
[TBL] [Abstract][Full Text] [Related]
20. Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.
Newman-Casey PA; Woodward MA; Niziol LM; Lee PP; De Lott LB
Ophthalmology; 2018 Mar; 125(3):332-339. PubMed ID: 28625684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
